Varex Imaging (NASDAQ:VREX) Director Jay Kunkel Sells 4,510 Shares

Key Points

• Director Jay Kunkel sold 4,510 shares on March 20 at an average price of $11.14 for $50,241.40, cutting his ownership by 16.13% to 23,450 shares (worth about $261,233).
• Varex beat quarterly estimates, reporting $0.19 EPS vs. $0.14 consensus on $209.6M revenue and issuing Q2 2026 guidance of $0.15–$0.25 EPS; analysts' consensus expects $0.53 EPS for the year and the average rating is "Hold" with a $16.17 price target.
• Stock snapshot: shares traded around $10.82 midday, market cap ~$453.36M, PE -6.60, and a 52-week range of $6.76–$14.56.

Varex Imaging (NASDAQ:VREX - Get Free Report) Director Jay Kunkel sold 4,510 shares of the company's stock in a transaction on Friday, March 20th. The stock was sold at an average price of $11.14, for a total transaction of $50,241.40. Following the sale, the director directly owned 23,450 shares in the company, valued at $261,233. This trade represents a 16.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Varex Imaging Stock Performance

Shares of VREX traded up $0.16 during midday trading on Monday, reaching $10.82. The stock had a trading volume of 322,384 shares, compared to its average volume of 343,347. The firm has a market cap of $453.36 million, a PE ratio of -6.60 and a beta of 0.88. The firm has a 50 day simple moving average of $13.11 and a 200-day simple moving average of $12.26. Varex Imaging has a one year low of $6.76 and a one year high of $14.56. The company has a current ratio of 3.89, a quick ratio of 1.87 and a debt-to-equity ratio of 0.75.

Varex Imaging (NASDAQ:VREX - Get Free Report) last issued its earnings results on Tuesday, February 10th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.14 by $0.05. The company had revenue of $209.60 million during the quarter, compared to the consensus estimate of $207.83 million. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. As a group, sell-side analysts anticipate that Varex Imaging will post 0.53 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on VREX shares. Wall Street Zen upgraded Varex Imaging from a "buy" rating to a "strong-buy" rating in a research note on Saturday, February 28th. B. Riley Financial reiterated a "buy" rating on shares of Varex Imaging in a research report on Thursday, February 12th. Jefferies Financial Group restated a "hold" rating and issued a $14.50 price target on shares of Varex Imaging in a research report on Monday, February 2nd. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Varex Imaging in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $16.17.

Hedge Funds Weigh In On Varex Imaging

Several institutional investors have recently added to or reduced their stakes in the business. LSV Asset Management raised its stake in Varex Imaging by 210.7% during the 4th quarter. LSV Asset Management now owns 1,244,329 shares of the company's stock worth $14,496,000 after buying an additional 843,805 shares during the period. Millennium Management LLC lifted its position in Varex Imaging by 119.8% in the 3rd quarter. Millennium Management LLC now owns 913,169 shares of the company's stock valued at $11,323,000 after acquiring an additional 497,650 shares in the last quarter. Qube Research & Technologies Ltd lifted its position in Varex Imaging by 2,514.9% in the 2nd quarter. Qube Research & Technologies Ltd now owns 318,127 shares of the company's stock valued at $2,758,000 after acquiring an additional 305,961 shares in the last quarter. Deerfield Management Company L.P. acquired a new position in Varex Imaging during the 3rd quarter valued at about $3,537,000. Finally, Neuberger Berman Group LLC increased its holdings in Varex Imaging by 22.8% during the 2nd quarter. Neuberger Berman Group LLC now owns 1,497,175 shares of the company's stock worth $12,974,000 after purchasing an additional 277,870 shares in the last quarter.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company's medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.